by Raynovich Rod | Aug 28, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Life Science Sector Update August 2024 Nothing seems be happening lately in the market as we wait for Nvidia earnings. It’s the slowest week of the year, we are at the market top and most earnings reports are good. And FED Chairman Powell recently indicated a...
by Raynovich Rod | Aug 20, 2024 | 2023-24 Life Science Portfolios, Biopharmaceuticals
Update-2 8/26/24….On a 3 day weekend so no new post till Wednesday. It’s a quiet week with many people taking off before Labor Day weekend. Some big SMID movers today so check them out: CRMD up over 9% , DNLI up 3.31%, IMTX up over 3%, RZLT up 8%, All...
by Raynovich Rod | Aug 13, 2024 | 2023-24 Life Science Portfolios, Biopharmaceuticals
Update-2 8/19..11:15 am EDT…RALLY in SMID biotechs continue with moves in ARKG and XBI. UPDATE-1 12n AUG 15…MOmentum is picking up in our SMID trading list. We are long bellwether XBI and added ARK Genomic Revolution (ARKG) as a trade because this ETF has...
by Raynovich Rod | Jul 29, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
8/2 …10a EST: Port in the storm in this volatile rotation ? healthcare stocks: ABT,INSP, MRK, REGN, UNH etc. 8/1..3:10P EST…Massive reversal down for chip stocks and tech in general. Only green on my screen are large cap biopharmas: ABBV, GILD, LLY,...
by Raynovich Rod | Jul 22, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-1 JY 24…Healthcare Stocks held up well during today’s technology sell-off. NASDAQ stocks took a big hit today with the QQQ down 3.59%.We can say it was caused by the Google earnings report as technology analysts tried to read beyond the actual...
by Raynovich Rod | Jul 15, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio
Update-3 JY 19…3:15 EST.. Market still down little but coming back. CNBC offering positive comments on biotech, tape looks better. I had a nervous trigger finger yesterday selling my profitable NTRA and its coming back today but Ill wait to get back...
by Raynovich Rod | Jul 8, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update-3 …7/11…SMID biotechs rally on a big rotation day out of MEGA Cap tech.XBI up 2.67% “kissing” the $98 level.Nibble on our Life Science trading list as it is another “green screen ” day. Even the IBB broke through $140 today...
by Raynovich Rod | Jul 1, 2024 | 2023-24 Life Science Portfolios, Biopharmaceuticals
Update- 7/6…The XBI model works as expected-if the XBI has momentum the chances are very good your SMID biotech stock will rally. The following stocks show gains or minimal losses over the past year. Stocks showing trading gains are : ADPT, CRSP, GERN, NTRA,...
by Raynovich Rod | Jun 10, 2024 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Healthcare stocks
Update-4…6/29….I’m back but I did not miss much in biotech trades, but a lot of “3 day wonders'” you know stocks that get momentum then quickly fade. The XBI is still holding above the $90 support level with a range of $89.13 to $94.88...
by Raynovich Rod | May 28, 2024 | 2023-24 Life Science Portfolios, Life Science ETF's and Mutual Funds
Update: 6/7/24.,,Our model still looks good for experienced traders.Today for example GERON (GERN) soared 19% with approval of RYTELO for MDS associated anemia. We will summarize news from winning stocks over the weekend. XBI was weak today down about 1% to $91...
